SMi Group’s 13th Annual Conference: RNA Therapeutics 2022 9th – 10th February 2022 Virtual Conference: Online Access Only www.therapeutics-rna.com Sponsored by: BIA Separations | eTheRNA Immunotherapies | Thermo Fisher Scientific Bolstering the latest advances and opportunities in RNA-based medicine The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading […]

SMi’s 5th Annual 3D Cell Culture Conference Virtual Conference: Online Access Only 9-10 February 2022 http://www.3d-cellculture.com/ Sponsored by: CELLINK, CelVivo, Promega and Newcells BiotechDeveloping Complex, Translatable and Physiologically-Relevant Cellular Models in vitro Conference Co-Chairs: Stefan Przyborski, Professor of Cell Technology, Durham University and Philip Hewitt, Global Head of Early Investigative Toxicology, Merck 3D Cell Culture is […]

From Translation to Market-Entry: Advance Formulation, Clinical Development, & Commercialization of Phage-Based Therapies at the 4th Bacteriophage Therapy Summit 2022. Returning for its 4th year, the Bacteriophage Therapy Summit remains the only industry-focused forum dedicated to facilitating the discovery, translation & acceleration of bacteriophage research into targeted therapeutics with clinically significant results. View the full […]

This 2nd Operationalize: Expanded Access Programs summit is here to bring you solutions. By bringing together the world’s leading Expanded Access Programs thinkers, this exclusive platform will clarify the complex issues through end-to-end Managed Access/Compassionate Use program operationalization. Through open discussion, sharing best-practice case studies, and removing hypotheticals: this event provides an unrivaled opportunity to solve your challenges across […]

LEAP HR: Life Sciences Europe is your best opportunity to uncover the brand-new HR thinking that will enable you to tackle an ongoing talent shortage, and create the differentiated people strategies and organisational agendas you need to thrive in a hybrid life sciences operating environment. Step inside 20+ case studies of how biopharma organisations of all sizes are […]

The Only Global RAS Dedicated Conference is Returning in 2022 with the 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit! Year on year, we are proud to unite the leading frontiers of the RAS industry to showcase expertise, technical data and pipeline updates, all geared toward accelerating the discovery and development of anti-RAS therapies. This February […]

As the CAR-T field continues to explode with new companies, investment, and clinical collaborations, it's more important than ever to stay ahead of the curve. Stakeholders across oncology are now turning to next generation developments and innovations to create the therapies of tomorrow. That’s why CAR-TCR Europe has evolved into the Next Generation CAR-TCR Summit: your […]

We are happy to announce that the Mitochondria-Targeted Drug Development Summit, focused on the pursuit for novel effective therapies for mitochondrial disorders/dysfunction, will be delivered in-person, for its 2nd edition. Mitobridge/Astellas, Minovia Therapeutics, Abliva, GenSight Biologics, Stealth Biotherapeutics and many more will unite drive to better understand how to create effective and scalable mitochondrial therapies. […]

As SGLT2 inhibitors redefine standard of care, opportunities to establish efficacy with surrogate endpoints take a step forward, and molecular phenotyping of disease etiology enables reclassification of patients to clinically actionable subtypes; drug development for chronic kidney disease has never been more exciting. The 4th Chronic Kidney Disease Drug Development Summit is your only industry-led event dedicated […]